|
|
|
| |
|
|
| |
The latest oncology news from News Medical |
|
|
|
 | | |  Vitamin A derivative suppresses immune response and cancer vaccine efficacy Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by which a metabolic derivative of vitamin A-all-trans retinoic acid-compromises both the body's normal anti-cancer immune response and, in a different context, the efficacy of a promising type of cancer vaccine. | | | | |  A mathematical solution for precise control of cellular “noise” Why does cancer sometimes recur after chemotherapy? Why do some bacteria survive antibiotic treatment? In many cases, the answer appears to lie not in genetic differences, but in biological noise - random fluctuations in molecular activity that occur even among genetically identical cells. | | | | |  Elevated bacteria levels in tumors weaken immune response, studies show Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why immunotherapy works for some patients but not others. | | | | |  What are the latest advances in cancer research and treatment? In the 21st century, technology has transformed every aspect of life – from smartphones connecting the world, to social media reshaping communication, to AI revolutionizing industries. Cancer treatment has undergone its own shift: from chemotherapies to precise monoclonal therapy, targeted therapies, and immunotherapies. Image Credit: PeopleImages/Shutterstock. | |
|
|
| | | | |  Avatar Medical transforms CT and MRI scans into interactive 3D models, enhancing understanding for clinicians and patients in surgical planning and education. | | | | | Cancer has long remained a leading cause of death worldwide and in Hong Kong, accounting for 30% of all disease-related deaths in the city in 2025. While chemotherapy remains a major treatment modality, its side effects and the risk of relapse challenges for patients. | | | | | A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen treatment for women with breast cancer, a new Cambridge-led trial has found. | |
|
|
|
|
|
|
|
